Search research articles
Contact Us
Filters
Showing results (51-60 of 95) with videos related to
Page
of 10
Sort By:
Clinical Proteomics
|
October 23, 2020
A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease
Scott Bringans, Jason Ito, Tammy Casey, et al.
Proteomics
|
February 18, 2010
Use of SELDI MS to discover and identify potential biomarkers of toxicity in InnoMed PredTox: a multi-site, multi-compound study
Ben C Collins, Alexandra Sposny, Diane McCarthy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 11, 2021
Identification and Evaluation of Serum Protein Biomarkers That Differentiate Psoriatic Arthritis From Rheumatoid Arthritis
Angela Mc Ardle, Anna Kwasnik, Agnes Szentpetery, et al.
Current Rheumatology Reports
|
September 22, 2020
Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMAN
Stacie Bell, Joseph F Merola, Dan E Webster, et al.
Rheumatic Diseases Clinics of North America
|
April 17, 2026
Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis
Andre Lucas Ribeiro, Anne Barton, Jochen M Schwenk, et al.
ESC Heart Failure
|
March 29, 2021
Multiplexed measurement of candidate blood protein biomarkers of heart failure
Claire Tonry, Ken McDonald, Mark Ledwidge, et al.
Journal of Proteome Research
|
December 17, 2009
Prioritization of candidate protein biomarkers from an in vitro model system of breast tumor progression toward clinical verification
Thomas Y K Lau, Karen A Power, Sophie Dijon, et al.
Chemical Research in Toxicology
|
January 11, 2011
Sequence tagging reveals unexpected modifications in toxicoproteomics
Surendra Dasari, Matthew C Chambers, Simona G Codreanu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 10, 2009
The microtubule-targeting agents, PBOX-6 [pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and paclitaxel, induce nucleocytoplasmic redistribution of the peptidyl-prolyl isomerases, cyclophilin A and pin1, in malignant hematopoietic cells
Fiona T Bane, John H Bannon, Stephen R Pennington, et al.
The Journal of Rheumatology
|
July 15, 2024
GRAPPA 2023 Collaborative Research Network Meeting
Vinod Chandran, Dafna D Gladman, Philip J Mease, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 95) with videos related to
Sort By:
Page
of 10
Clinical Proteomics
|
October 23, 2020
A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease
Scott Bringans, Jason Ito, Tammy Casey, et al.
Proteomics
|
February 18, 2010
Use of SELDI MS to discover and identify potential biomarkers of toxicity in InnoMed PredTox: a multi-site, multi-compound study
Ben C Collins, Alexandra Sposny, Diane McCarthy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 11, 2021
Identification and Evaluation of Serum Protein Biomarkers That Differentiate Psoriatic Arthritis From Rheumatoid Arthritis
Angela Mc Ardle, Anna Kwasnik, Agnes Szentpetery, et al.
Current Rheumatology Reports
|
September 22, 2020
Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMAN
Stacie Bell, Joseph F Merola, Dan E Webster, et al.
Rheumatic Diseases Clinics of North America
|
April 17, 2026
Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis
Andre Lucas Ribeiro, Anne Barton, Jochen M Schwenk, et al.
ESC Heart Failure
|
March 29, 2021
Multiplexed measurement of candidate blood protein biomarkers of heart failure
Claire Tonry, Ken McDonald, Mark Ledwidge, et al.
Journal of Proteome Research
|
December 17, 2009
Prioritization of candidate protein biomarkers from an in vitro model system of breast tumor progression toward clinical verification
Thomas Y K Lau, Karen A Power, Sophie Dijon, et al.
Chemical Research in Toxicology
|
January 11, 2011
Sequence tagging reveals unexpected modifications in toxicoproteomics
Surendra Dasari, Matthew C Chambers, Simona G Codreanu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 10, 2009
The microtubule-targeting agents, PBOX-6 [pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and paclitaxel, induce nucleocytoplasmic redistribution of the peptidyl-prolyl isomerases, cyclophilin A and pin1, in malignant hematopoietic cells
Fiona T Bane, John H Bannon, Stephen R Pennington, et al.
The Journal of Rheumatology
|
July 15, 2024
GRAPPA 2023 Collaborative Research Network Meeting
Vinod Chandran, Dafna D Gladman, Philip J Mease, et al.
Page
of 10